OptimizeRx Corporation
OPRX
$17.00
-$0.25-1.45%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -9.87M | -15.41M | -20.11M | -24.17M | -17.92M |
| Total Depreciation and Amortization | 4.57M | 4.57M | 4.57M | 4.25M | 3.66M |
| Total Amortization of Deferred Charges | 1.10M | 847.00K | 835.00K | 848.00K | 622.00K |
| Total Other Non-Cash Items | 15.92M | 17.33M | 18.93M | 26.13M | 21.10M |
| Change in Net Operating Assets | -1.31M | -704.00K | 671.00K | -8.61M | -9.36M |
| Cash from Operations | 10.41M | 6.64M | 4.89M | -1.57M | -1.89M |
| Capital Expenditure | -72.00K | -107.00K | -112.00K | -100.00K | -115.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 10.00K | 10.00K |
| Cash Acquisitions | -- | -- | -- | -82.95M | -82.95M |
| Divestitures | -- | -- | -- | 2.54M | 2.54M |
| Other Investing Activities | -268.00K | -274.00K | -338.00K | 54.17M | 53.26M |
| Cash from Investing | -340.00K | -381.00K | -450.00K | -26.33M | -27.25M |
| Total Debt Issued | -- | -- | -- | 37.73M | 37.73M |
| Total Debt Repaid | -8.00M | -4.00M | -4.00M | -3.21M | -2.71M |
| Issuance of Common Stock | -- | -- | -- | 15.00K | 16.00K |
| Repurchase of Common Stock | -448.00K | -858.00K | -911.00K | -733.00K | -750.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 300.00K | 0.00 |
| Cash from Financing | -8.45M | -4.86M | -4.91M | 34.10M | 34.29M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -1.00K | 0.00 |
| Net Change in Cash | 1.63M | 1.40M | -472.00K | 6.20M | 5.15M |